Neogen Corporation (NEOG) Stock Score, Valuation & Financial Research
Neogen Corporation is in the Healthcare sector and Medical - Devices industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 21/100.
Quick answer for NEOG
Neogen Corporation currently has a Wall Street Score of 21/100. The stored market price is $11.95. Its financial score is 30/100. Its valuation score is 0/100. These figures are a research snapshot, not a buy or sell recommendation.
What Neogen Corporation does
Neogen Corporation, including its affiliated companies, is a global leader in creating, manufacturing, and distributing a wide range of products crucial for maintaining food quality and animal health. The enterprise is structured into two primary divisions: Food Safety and Animal Safety. The Food Safety segment delivers advanced diagnostic test kits and associated solutions to identify detrimental or unintended contaminants in food and animal feed. This extensive detection capability covers threats such as foodborne pathogens, spoilage-causing organisms, naturally occurring toxins, food allergens, genetically modified ingredients, ruminant by-products, specific meat identification, residual drugs and pesticides, and overall sanitation issues. A key product is the AccuPoint Advanced rapid sanitation test, which quickly spots adenosine triphosphate (ATP), indicating the presence of living
NEOG financial snapshot
- Wall Street Score:
- 21/100
- Current price:
- $11.95
- Market capitalization:
- $2.61B
- Revenue:
- $870.5M
- Net income:
- $-608.8M
- Free cash flow:
- $-46.4M
- Cash:
- $159.9M
- Total debt:
- $793.3M
- EPS:
- -5.03
- Financial score:
- 30/100
- Valuation score:
- 0/100
- Revenue score:
- 8/100
What stands out
- Reported year-over-year revenue growth is -0.0%.
- Free cash flow is $-46.4M, showing cash burn in the current stored period.
- The balance sheet shows $159.9M of cash versus $793.3M of total debt, so leverage deserves attention.
What the numbers mean
Its current valuation score is 0/100, which Wall Street Score classifies as weak within the model's valuation framework.
The financial score is 30/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-07-24.
How to research NEOG
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.